Serum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients
Kasturi Banerjee, Michael P. Motley, Elizabeth Diago‐Navarro, Bettina C. Fries
Abstract
Carbapenem-resistant Klebsiella pneumoniae is a rapidly emerging public health threat that can cause fatal infections in up to 50% of affected patients. Due to its resistance to nearly all antimicrobials, development of alternate therapies like antibodies and vaccines is urgently needed.
Topics & Concepts
Klebsiella pneumoniaeAntibodyMicrobiologyPhagocytosisSerotypeTiterImmunoglobulin GMedicineImmunologyBiologyEscherichia coliBiochemistryGeneAntibiotic Resistance in BacteriaPneumonia and Respiratory InfectionsAntibiotics Pharmacokinetics and Efficacy